Molecular characterisation of group A streptococci from invasive and non-invasive disease episodes in Belgium during 1993-1994

Journal of Medical Microbiology

Volumn 49, Issue 5, 2000, Pages 467-471

  Descheemaeker, P ^a   Van Loock, F ^b   Hauchecorne, M ^a   Vandamme, P ^a   Goossens, H ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; EXOTOXIN; PYROGEN; SUPERANTIGEN; VIRULENCE FACTOR;

ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BELGIUM; CLONE; CONTROLLED STUDY; GENE SEQUENCE; INFORMATION PROCESSING; MOLECULAR GENETICS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; STRAIN DIFFERENCE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; TOXIC SHOCK SYNDROME;

EID: 0034062707     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-49-5-467     Document Type: Article

References (39)

1. 1. Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med 1991; 325: 783-793.
2. 2. Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med 1996; 334: 240-245.
3. 3. Demers B, Simor AE, Vellend H et al. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis 1993; 16: 792-800.
4. 4. Denny FW. A 45-year perspective on the streptococcus and rheumatic fever: The Edward H. Kass lecture in infectious disease history. Clin Infect Dis 1994; 19: 1110-1122.
5. 5. Stevens DL. Invasive group A streptococcus infections. Clin Infect Dis 1992; 14: 2-13.
6. 6. Holm SE, Norrby A, Bergholm A-M, Norgren M. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis 1992; 166: 31-37.
7. 7. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. JAMA 1993; 269: 384-389.
8. 8. Katz AR, Morens DM. Severe streptococcal infections in historical perspective. Clin Infect Dis 1992; 14: 298-307.
9. 9. Stevens DL, Tanner MH, Winship J et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321: 1-7.
10. 10. Musser JM, Kapur V, Szeto J, Pan X, Swanson DS, Martin DR. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent international spread of a subclone causing episodes of invasive disease. Infect Immun 1995; 63: 994-1003.
11. 11. Desai M, Efstratiou A, George R, Stanley J. High-resolution genotyping of Streptococcus pyogenes serotype M1 isolates by fluorescent amplified-fragment length polymorphism analysis. J Clin Microbiol 1999; 37: 1948-1952.
12. 12. Hoe N, Nakashima K, Grigsby D et al. Rapid molecular genetic subtyping of serotype M1 group A Streptococcus strains. Emerg Infect Dis 1999; 5: 254-263.
13. 13. Norrby-Teglund A, McGeer A, Low D, Kotb M. Superantigenicity and Vβ-specificity of culture supernatants from streptococcal toxic shock syndrome Streptococcus pyogenes isolates. In: XIIIth Lancefield International Symposium on Streptococci and Streptococcal Diseases, 16-20 Sept. 1996. Montreuil-Sous-Bois, France, Orane Communication Graphique. 1996.
14. 14. Reda KB, Kapur V, Goela D, Lamphear JG, Musser JM, Rich RR. Phylogenetic distribution of streptococcal superantigen SSA allelic variants provides evidence for horizontal transfer of ssa within Streptococcus pyogenes. Infect Immun 1996; 64: 1161-1165.
15. 15. The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA 1993; 269: 390-391.
16. 16. Descheemaeker P, Lammens C, Pot B, Vandamme P, Goossens H. Evaluation of arbitrarily primed PCR analysis and pulsedfield gel electrophoresis of large genomic DNA fragments for identification of enterococci important in human medicine. Int J Syst Bacteriol 1997; 47: 555-561.
17. 17. Kaufhold A, Podbielski A, Baumgarten G, Blokpoel M, Top J, Schouls L. Rapid typing of group A streptococci by the use of DNA amplification and non-radioactive allele-specific oligonucleotide probes. FEMS Microbiol Lett 1994; 119: 19-26.
18. 18. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsedfield gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
19. 19. Goossens H, Chapelle S, Hauchecorne M, Wijdooghe M, Descheemaeker P. Characterization of macrolide resistance among group A Streptococcus in Belgium [abstract C-14]. In: Program and Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy (New York). San Diego, California: American Society for Microbiology. 1998.
20. 20. Sutcliffe J, Tait-Kamradt A, Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 1996; 40: 1817-1824.
21. 21. Nguyen L, Levy D, Ferroni A, Gehanno P, Berche P. Molecular epidemiology of Streptococcus pyogenes in an area where acute pharyngotonsillitis is endemic. J Clin Microbiol 1997; 35: 2111-2114.
22. 22. Davies HD, McGeer A, Schwartz B et al. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med 1996; 335: 547-554.
23. 23. Musser JM, Hauser AR, Kim MH, Schlievert PM, Nelson K, Selander RK. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: Clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci USA 1991; 88: 2668-2672.
24. 24. Stanley J, Linton D, Desai M, Efstratiou A, George R. Molecular subtyping of prevalent M serotypes of Streptococcus pyogenes causing invasive disease. J Clin Microbiol 1995; 33: 2850-2855.
25. 25. Muotiala A, Seppälä H, Huovinen P, Vuopio-Varkila J. Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland. J Infect Dis 1997; 175: 392-399.
26. 26. Kiska DL, Thiede B, Caracciolo J et al. Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis 1997; 176: 992-1000.
27. 27. Nakashima K, Ichiyama S, Iinuma Y et al. A clinical and bacteriological investigation of invasive streptococcal infections in Japan on the basis of serotypes, toxin production, and genomic DNA fingerprints. Clin Infect Dis 1997; 25: 260-266.
28. 28. Hauser AR, Stevens DL, Kaplan EL, Schlievert PM. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J Clin Microbiol 1991; 29: 1562-1567.
29. 29. Johnson DR, Stevens DL, Kaplan EL. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 1992; 166: 374-384.
30. 30. Reichardt W, Müller-Alouf H, Alouf JE, Köhler W. Erythrogenic toxins A, B and C: occurrence of the genes and exotoxin formation from clinical Streptococcus pyogenes strains associated with streptococcal toxic shock-like syndrome. FEMS Microbiol Lett 1992; 100: 313-322.
31. 31. Black CM, Talkington DF, Messmer TO, Facklam RR, Hornes E, Olsvik Ø. Detection of streptococcal pyrogenic exotoxin genes by a nested polymerase chain reaction. Mol Cell Probes 1993; 7: 255-259.
32. 32. Norrby-Teglund A, Newton D, Kotb M, Holm SE, Norgren M. Superantigenic properties of the group A streptococcal exotoxin speF (MF). Infect Immun 1994; 62: 5227-5233.
33. 33. Tyler SD, Johnson WM, Huang JC et al. Streptococcal erythrogenic toxin genes: detection by polymerase chain reaction and association with disease in strains isolated in Canada from 1940 to 1991. J Clin Microbiol 1992; 30: 3127-3131.
34. 34. Cleary PP, Kaplan EL, Handley JP et al. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet 1992; 339: 518-521.
35. 35. Hsueh P-R, Wu J-J, Tsai P-J, Liu J-W, Chuang Y-C, Luh K-T. Invasive group A streptococcal disease in Taiwan is not associated with the presence of streptococcal pyrogenic exotoxin genes. Clin Infect Dis 1998; 26: 584-589.
36. 36. Watanabe-Ohnishi R, Low DE, McGeer A et al. Selective depletion of Vβ-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. J Infect Dis 1995; 171: 74-84.
37. 37. Kotb M. Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 1995; 8: 411-426.
38. 38. Kamezawa Y, Nakahara T, Nakano S, Abe Y, Nozaki-Renard J, Isono T. Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes. Infect Immun 1997; 65: 3828-3833.
39. 39. Chaussee MS, Liu J, Stevens DL, Ferretti JJ. Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections. J Infect Dis 1996; 173: 901-908.